Danaher Corporation $DHR Shares Sold by Bessemer Group Inc.

Bessemer Group Inc. lowered its position in Danaher Corporation (NYSE:DHR) by 12.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,096,906 shares of the conglomerate’s stock after selling 292,056 shares during the quarter. Danaher accounts for about 0.7% of Bessemer Group Inc.’s investment portfolio, making the stock its 19th biggest position. Bessemer Group Inc.’s holdings in Danaher were worth $480,024,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $26,000. JPL Wealth Management LLC bought a new position in shares of Danaher in the third quarter valued at approximately $25,000. WFA of San Diego LLC bought a new position in shares of Danaher in the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher in the third quarter valued at approximately $27,000. Finally, Financial Life Planners bought a new position in shares of Danaher in the third quarter valued at approximately $32,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 10.80% of the company’s stock.

Danaher Trading Down 0.8%

Shares of NYSE:DHR opened at $164.59 on Friday. The stock has a market capitalization of $116.49 billion, a price-to-earnings ratio of 31.84, a PEG ratio of 2.22 and a beta of 0.81. Danaher Corporation has a 1-year low of $163.32 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company has a 50 day moving average price of $187.15 and a 200 day moving average price of $210.72.

Danaher (NYSE:DHR) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period last year, the firm posted $1.88 earnings per share. On average, research analysts anticipate that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Analyst Ratings Changes

Several research analysts have recently issued reports on DHR shares. Morgan Stanley decreased their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. KeyCorp reiterated an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Wells Fargo & Company decreased their price objective on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. TD Cowen decreased their price objective on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Finally, Robert W. Baird decreased their price objective on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a report on Friday, April 17th. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $238.65.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.